Use of CD63 inhibitors

Details Use of CD63 inhibitors Use of CD63 inhibitors

2006-08-15

2006-08-15

Schultz, James (Department: 1635)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S135100, C424S139100, C424S141100, C424S142100, C424S143100, C424S144100, C424S154100

Reexamination Certificate

active

07090841

ABSTRACT:
The invention provides a method of decreasing human immunodeficiency virus entry into cells, the method comprising decreasing levels of functional CD63 present with the human immunodeficiency virus and the cells. The invention further provides a method of treating or preventing human immunodeficiency virus infection in a subject, the method comprising administering to the subject an amount of a compound effective to decrease levels of functional CD63 in the cells of the subject.

REFERENCES:
Agrawal, S. Trends Biotechnol. Oct. 1996;14(10):376-87.
Braasch, D. A. Biochemistry. Apr. 2002; 41(14): 4503-4510.
Branch, A. D., (1998). Trends Biochem Sci. Feb. 1998;23(2):45-50.
Gewirtz et al., Proc. Natl. Acad. Sci. v 93, pp. 3161-3163.
Tamm, I. et al. The Lancet. Aug. 2001 358: 489-497.
McCune, SL et al., (Sep. 12, 2001) JAMA 286(10) 1149-1152.
Smith et al. Mol. Immunol. 1995. vol. 32, No. 17/18, pp. 1339-1344.
Audran at L., Immun. Meth. 1995, 188:147-154.

Affiliated with

Also associated with

Rating

Use of CD63 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of CD63 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of CD63 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3674483